Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NRIP2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | C19orf45 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | RWDD2A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | CHP1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
mRNA | HMX2 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
mRNA | STMN1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
mRNA | TSSK2 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
mRNA | CLCF1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
mRNA | AC002310.11 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
mRNA | EP400 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |